The ROC curves and AUC values of the diagnostic model. حسب Zhe Wu (582498)

ROC curve and AUC value of all models. حسب Tiago de Oliveira Barreto (20485207)

"…As for Specificity (82.94%) and ROC-AUC (82.13%), the Multilayer Perceptron with SGD optimizer obtained the highest scores. …"

Area under the curve (AUC) for external validation performance. حسب Junichi Kushioka (12236447)

Significantly Enriched Pathways. حسب Jiyong Zhang (2498740)

"…Pathway analysis revealed a marked decrease in expression within certain key metabolic pathways (such as the one-carbon pool by folate) in the NAFLD group, while expression in DNA repair-related pathways (such as non-homologous end joining) was significantly increased. …"

AUC of various models to predict imeglimin efficacy for liver function evaluated by ROC curves. حسب Naruyoshi Gyoutoku (22537831)

Column charts of WiAUC in therapy and control group at baseline and follow-up. حسب Felix L. Herr (21544362)

Table 5_Immune-related diagnostic indicators and targeted therapies for COPD combined with NASH were identified and verified via WGCNA and LASSO.xlsx حسب Jianwei Hong (6918776)

"…A nomogram diagnostic model was constructed based on these two core genes. The AUC value for S100A9 was 0.887, for MYH2 was 0.877, and for the nomogram was 0.889, demonstrating excellent diagnostic efficacy. …"

Table 1_Immune-related diagnostic indicators and targeted therapies for COPD combined with NASH were identified and verified via WGCNA and LASSO.xlsx حسب Jianwei Hong (6918776)

"…A nomogram diagnostic model was constructed based on these two core genes. The AUC value for S100A9 was 0.887, for MYH2 was 0.877, and for the nomogram was 0.889, demonstrating excellent diagnostic efficacy. …"

Table 4_Immune-related diagnostic indicators and targeted therapies for COPD combined with NASH were identified and verified via WGCNA and LASSO.xlsx حسب Jianwei Hong (6918776)

"…A nomogram diagnostic model was constructed based on these two core genes. The AUC value for S100A9 was 0.887, for MYH2 was 0.877, and for the nomogram was 0.889, demonstrating excellent diagnostic efficacy. …"

Table 3_Immune-related diagnostic indicators and targeted therapies for COPD combined with NASH were identified and verified via WGCNA and LASSO.xlsx حسب Jianwei Hong (6918776)

"…A nomogram diagnostic model was constructed based on these two core genes. The AUC value for S100A9 was 0.887, for MYH2 was 0.877, and for the nomogram was 0.889, demonstrating excellent diagnostic efficacy. …"

Table 6_Immune-related diagnostic indicators and targeted therapies for COPD combined with NASH were identified and verified via WGCNA and LASSO.xlsx حسب Jianwei Hong (6918776)

"…A nomogram diagnostic model was constructed based on these two core genes. The AUC value for S100A9 was 0.887, for MYH2 was 0.877, and for the nomogram was 0.889, demonstrating excellent diagnostic efficacy. …"

Table 2_Immune-related diagnostic indicators and targeted therapies for COPD combined with NASH were identified and verified via WGCNA and LASSO.xlsx حسب Jianwei Hong (6918776)

"…A nomogram diagnostic model was constructed based on these two core genes. The AUC value for S100A9 was 0.887, for MYH2 was 0.877, and for the nomogram was 0.889, demonstrating excellent diagnostic efficacy. …"

AUC ROC curve. حسب Dieuwke Luijten (15282736)

Statistical analysis of the AUC measurement. حسب Esra Ayan (21156015)

"…<p>Analysis indicated that INSv application significantly changed spontaneous calcium activity (IAsp <i>p</i>-value: 0.1290, INSv <i>p</i>-value: 0.0002). The mean AUC decreased in both samples.…"

Area under the ROC Curve (AUC) analysis to predict AIS conversion at 6-months and 1-year following acute cervical tSCI. حسب Harshit Arora (22008280)

Area under the ROC curve (AUC) analysis to predict neurological severity at 6-months and 1-year following acute cervical tSCI. حسب Harshit Arora (22008280)

Daily number of adverse outcomes (bars) and area under the precision-recall curve (AUC-PRC) per day of the fullPIERS model. حسب Guiyou Yang (10259597)

Daily number of adverse outcomes (bars) and area under the precision-recall curve (AUC-PRC) per day of the PIERS-ML model. حسب Guiyou Yang (10259597)

Correlation analysis of red blood cell-platelet ratio and coagulation indicators. حسب Jie Zhao (49409)

الموضوعات:

Univariate analysis of hospitalized patients. حسب Jie Zhao (49409)

الموضوعات: